Home/Filings/4/0001127602-13-007585
4//SEC Filing

Endicott David J. 4

Accession 0001127602-13-007585

CIK 0000850693other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 7:33 PM ET

Size

7.6 KB

Accession

0001127602-13-007585

Insider Transaction Report

Form 4
Period: 2013-02-20
Endicott David J.
CVP and President, AGN Med US
Transactions
  • Tax Payment

    Common Stock

    2013-02-20$108.08/sh2,794$301,97617,335 total
  • Award

    Employee Stock Option (Right to Buy)

    2013-02-21+40,00040,000 total
    Exercise: $105.87Exp: 2023-02-21Common Stock (40,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    3,113.565
Footnotes (3)
  • [F1]Exempt disposition to the issuer, effective 2/20/2013, transaction date, of a number of shares determined to be sufficient to satisfy tax withholding obligations resulting from the lapse of restrictions of an exempt award of 7,000 shares of restricted stock granted on 2/20/2009.
  • [F2]Shares allocated to the reporting person's ESOP account as of reporting date.
  • [F3]The option becomes exercisable in four equal annual installments beginning February 21, 2014.

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeother

Related Parties

1
  • filerCIK 0001532133

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:33 PM ET
Size
7.6 KB